A rendering of Thermo Fisher's new standalone, 130,000 square-foot facility to be built in Greenville, NC (Thermo Fisher)

Look­ing for an edge in vac­cines, Ther­mo Fish­er plots ma­jor ex­pan­sions across glob­al man­u­fac­tur­ing sites in its port­fo­lio

In a big year for con­tract man­u­fac­tur­ers, Mass­a­chu­setts’ Ther­mo Fish­er Sci­en­tif­ic has emerged as a lead­ing part­ner for drug­mak­ers fight­ing the Covid-19 pan­dem­ic, par­tic­u­lar­ly in di­ag­nos­tics and ther­a­peu­tics. Now, buoyed by that suc­cess and look­ing to scale up its vac­cine of­fer­ings, Ther­mo Fish­er is plot­ting big ex­pan­sion across its glob­al port­fo­lio.

Ther­mo Fish­er will ex­pand its fa­cil­i­ties in Greenville, NC; Fer­enti­no and Mon­za, Italy; and Swin­don, Eng­land, to ex­pand its range of of­fer­ings for cus­tomers”whether it’s an emerg­ing biotech work­ing on a vac­cine for a nov­el virus or a high-vol­ume phar­ma­ceu­ti­cal man­u­fac­tur­er de­liv­er­ing nec­es­sary med­i­cines at scale,” a spokesper­son told End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.